[Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application: gyneco-obstetrical diseases].
D000019:Abortifacient Agents; D000527:Alprostadil / Q000031:analogs & derivatives*; D015237:Dinoprost; D015232:Dinoprostone; D005260:Female; D006801:Humans; D007422:Intestines / Q000187:drug effects; D011247:Pregnancy; D011458:Prostaglandins E / Q000494:pharmacology; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use; D011460:Prostaglandins F / Q000494:pharmacology* / Q000627:therapeutic use; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D001743:Urinary Bladder / Q000187:drug effects; D014590:Uterine Contraction / Q000187:drug effects*; D014592:Uterine Hemorrhage / Q000188:drug therapy
D000019:Abortifacient Agents; D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; D011460:Prostaglandins F; D011465:Prostaglandins, Synthetic; C021182:gemeprost; D015237:Dinoprost; D000527:Alprostadil; D015232:Dinoprostone